NCT01165996 2019-03-04Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeCase Comprehensive Cancer CenterPhase 1/2 Completed25 enrolled 13 charts
NCT00450983 2017-05-24Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesFred Hutchinson Cancer CenterPhase 2 Terminated1 enrolled 5 charts